Ditchcarbon
  • Contact
  1. Organizations
  2. OctoPlus N.V.
Public Profile
Pharmaceutical Preparation Manufacturing
NL
updated a month ago

OctoPlus N.V. Sustainability Profile

Company website

OctoPlus N.V., headquartered in the Netherlands, is a prominent player in the biopharmaceutical industry, specialising in the development of innovative drug delivery systems. Founded in 2000, the company has achieved significant milestones, including advancements in its proprietary technology platforms that enhance the efficacy and safety of therapeutic agents. With a focus on injectable formulations, OctoPlus offers unique services that cater to the specific needs of pharmaceutical companies, including formulation development and clinical trial support. Their expertise in complex drug delivery systems positions them as a trusted partner in the industry. Recognised for their commitment to quality and innovation, OctoPlus N.V. continues to strengthen its market position, contributing to the advancement of healthcare solutions globally.

DitchCarbon Score

How does OctoPlus N.V.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

93

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

31

Industry Benchmark

OctoPlus N.V.'s score of 93 is higher than 96% of the industry. This can give you a sense of how well the company is doing compared to its peers.

96%

Let us know if this data was useful to you

OctoPlus N.V.'s reported carbon emissions

Inherited from Dr. Reddy's Laboratories Limited

OctoPlus N.V., headquartered in the Netherlands (NL), currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of Dr. Reddy's Laboratories Limited, which influences its climate commitments and initiatives. As part of its corporate family relationship, OctoPlus N.V. inherits climate-related targets and performance metrics from Dr. Reddy's Laboratories Limited. This includes commitments to the Science Based Targets initiative (SBTi) and participation in the Carbon Disclosure Project (CDP), both of which are cascaded down from the parent company. However, specific reduction targets or achievements for OctoPlus N.V. have not been detailed. In the context of industry standards, OctoPlus N.V. aligns with broader climate initiatives through its association with Dr. Reddy's Laboratories Limited, which is actively engaged in reducing its carbon footprint and enhancing sustainability practices. The absence of direct emissions data suggests a need for further transparency and reporting in line with global climate commitments.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

20152016201720182019202020212022202320242025
Scope 1
177,841,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
Scope 2
254,563,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
00,000,000
Scope 3
-
-
-
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000

How Carbon Intensive is OctoPlus N.V.'s Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. OctoPlus N.V.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is OctoPlus N.V.'s Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for OctoPlus N.V. is in NL, which has a very low grid carbon intensity relative to other regions.

OctoPlus N.V.'s Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

OctoPlus N.V. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare OctoPlus N.V.'s Emissions with Industry Peers

Takeda

JP
•
Pharmaceutical Preparation Manufacturing
Updated 20 minutes ago

Amgen

US
•
Pharmaceutical Preparation Manufacturing
Updated 7 days ago

Eli Lilly and Company

GB
•
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Lifecycle Pharma, Inc.

US
Updated about 1 month ago

Roche Holding AG

CH
•
Pharmaceutical Preparation Manufacturing
Updated 11 days ago

Sanofi

FR
•
Pharmaceutical Preparation Manufacturing
Updated about 2 hours ago

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251030.3
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy